Arcus Biosciences Inc.

NYSE: RCUS · Real-Time Price · USD
10.37
0.46 (4.64%)
At close: Aug 15, 2025, 3:59 PM
10.64
2.60%
After-hours: Aug 15, 2025, 07:29 PM EDT

Arcus Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
262M 141M 258M 263M 247M 237M 117M 119.66M 120.66M 118.66M 111.66M 432.5M 408.96M 391.42M 382.88M 37.87M 92.94M 85.23M
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
262M 141M 258M 263M 247M 237M 117M 119.66M 120.66M 118.66M 111.66M 432.5M 408.96M 391.42M 382.88M 37.87M 92.94M 85.23M
Operating Income
-338M -436M -330M -318M -293M -270M -340M -323.44M -313.44M -299.44M -280.44M 75.27M 67.13M 59.99M 54.25M -279.03M -199.34M -168.58M
Interest Income
47M 50M 52M 51M 49M 45M 41M 37.54M 30.54M 24.54M 15.54M 8M 3.16M 327K 481K 640K 749K 884K
Pretax Income
-306M -391M -283M -269M -246M -227M -301M -288.46M -284.46M -277.46M -266.46M 82.18M 69.21M 60.24M 54.65M -278.39M -198.59M -167.7M
Net Income
-306M -391M -283M -270M -249M -231M -307M -293.46M -287.46M -279.46M -267.46M 79.37M 66.39M 57.42M 52.83M -278.39M -198.59M -167.7M
Selling & General & Admin
115M 116M 120M 121M 121M 119M 117M 115.9M 111.9M 109.9M 103.9M 99.3M 89.64M 80.47M 72.29M 61.78M 56.61M 51.22M
Research & Development
485M 461M 448M 440M 399M 368M 340M 327.2M 322.2M 308.2M 288.2M 257.94M 252.19M 250.96M 256.35M 255.12M 235.67M 202.59M
Other Expenses
n/a n/a 20M 20M 20M 20M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
600M 577M 588M 581M 540M 507M 457M 443.1M 434.1M 418.1M 392.1M 357.23M 341.83M 331.43M 328.63M 316.9M 292.28M 253.81M
Interest Expense
6M 4M 4M 2M 2M 2M 2M 2.56M 1.56M 2.56M 1.56M 1.26M 1.26M 260K 260K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
600M 577M 588M 581M 540M 507M 457M 443.1M 434.1M 418.1M 392.1M 357.23M 341.83M 331.43M 328.63M 316.9M 292.28M 253.81M
Income Tax Expense
1M 1M 1M 1M 3M 4M 6M 5M 3M 2M 996K 2.81M 2.81M 2.81M 1.81M n/a n/a n/a
Shares Outstanding (Basic)
106.1M 98.4M 91.7M 91.4M 91.1M 86.2M 75M 74.6M 73.2M 73M 72.6M 72.2M 71.8M 71.19M 70.4M 70.11M 69.75M 67.08M
Shares Outstanding (Diluted)
106.5M 98.4M 91.7M 91.4M 91.1M 86.2M 75M 74.6M 73.2M 73M 72.6M 72.24M 71.81M 71.19M 75.36M 70.11M 69.75M 67.08M
EPS (Basic)
-3.18 -4.2 -3.11 -3.16 -3.1 -3.1 -4.15 -3.99 -3.88 -3.76 -3.62 1.27 1.00 0.81 0.69 -4.1 -2.96 -2.8
EPS (Diluted)
-3.18 -4.2 -3.11 -3.16 -3.1 -3.1 -4.15 -3.99 -3.88 -3.76 -3.62 1.01 0.74 0.55 0.43 -4.1 -2.96 -2.8
EBITDA
-282M -377M -269M -257M -235M -216M -291M -279.42M -275.42M -267.42M -258.42M 88.92M 74.91M 63.76M 57.97M -274.15M -194.58M -163.87M
EBIT
-292M -387M -279M -267M -244M -225M -299M -285.9M -282.9M -274.9M -264.9M 83.92M 70.95M 60.98M 55.39M -278.55M -199.02M -168.43M
Depreciation & Amortization
10M 10M 10M 10M 9M 9M 8M 6.48M 7.48M 7.48M 6.48M 4.56M 3.52M 2.34M 2.14M 4.4M 4.44M 4.56M